These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 12464009)

  • 1. Microbial entry through caveolae: variations on a theme.
    Duncan MJ; Shin JS; Abraham SN
    Cell Microbiol; 2002 Dec; 4(12):783-91. PubMed ID: 12464009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Caveolae as portals of entry for microbes.
    Shin JS; Abraham SN
    Microbes Infect; 2001 Jul; 3(9):755-61. PubMed ID: 11489424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Caveolae in the uptake and targeting of infectious agents and secreted toxins.
    Norkin LC
    Adv Drug Deliv Rev; 2001 Jul; 49(3):301-15. PubMed ID: 11551401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell biology. Caveolae--not just craters in the cellular landscape.
    Shin JS; Abraham SN
    Science; 2001 Aug; 293(5534):1447-8. PubMed ID: 11520975
    [No Abstract]   [Full Text] [Related]  

  • 5. The role of the epidermal growth factor receptor in microbial infections of the gastrointestinal tract.
    Buret A; Gall DG; Olson ME; Hardin JA
    Microbes Infect; 1999 Nov; 1(13):1139-44. PubMed ID: 10572318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipid rafts, caveolae, caveolin-1, and entry by Chlamydiae into host cells.
    Stuart ES; Webley WC; Norkin LC
    Exp Cell Res; 2003 Jul; 287(1):67-78. PubMed ID: 12799183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [New pathogenic enteral agents].
    Constantiniu S; Ambăruş A
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Bacteriol Virusol Parazitol Epidemiol; 1989; 34(2):177-83. PubMed ID: 2675271
    [No Abstract]   [Full Text] [Related]  

  • 8. The essential features of microorganisms and the rationale for antimicrobial therapy.
    Douglas CW
    Br Dent J; 1992 May; 172(9):339-43. PubMed ID: 1389584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Germs].
    Calbo Torrecillas F
    An Esp Pediatr; 1989 Sep; 31 Suppl 38():165-72. PubMed ID: 2490616
    [No Abstract]   [Full Text] [Related]  

  • 10. Host-pathogen interactions: the attributes of virulence.
    Casadevall A; Pirofski L
    J Infect Dis; 2001 Aug; 184(3):337-44. PubMed ID: 11443560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipid rafts and HIV-1: from viral entry to assembly of progeny virions.
    Campbell SM; Crowe SM; Mak J
    J Clin Virol; 2001 Oct; 22(3):217-27. PubMed ID: 11564586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Co-option of endocytic functions of cellular caveolae by pathogens.
    Shin JS; Abraham SN
    Immunology; 2001 Jan; 102(1):2-7. PubMed ID: 11168630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What is a pathogen?
    Casadevall A; Pirofski LA
    Ann Med; 2002; 34(1):2-4. PubMed ID: 12014430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microbial pathogenesis: lipid rafts as pathogen portals.
    Rosenberger CM; Brumell JH; Finlay BB
    Curr Biol; 2000 Nov; 10(22):R823-5. PubMed ID: 11102822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unraveling the role of membrane microdomains during microbial infections.
    Bagam P; Singh DP; Inda ME; Batra S
    Cell Biol Toxicol; 2017 Oct; 33(5):429-455. PubMed ID: 28275881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathogens: raft hijackers.
    Mañes S; del Real G; Martínez-A C
    Nat Rev Immunol; 2003 Jul; 3(7):557-68. PubMed ID: 12876558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The weapon potential of a microbe.
    Casadevall A; Pirofski LA
    Trends Microbiol; 2004 Jun; 12(6):259-63. PubMed ID: 15165603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of lipid rafts in the pathogenesis of bacterial infections.
    Zaas DW; Duncan M; Rae Wright J; Abraham SN
    Biochim Biophys Acta; 2005 Dec; 1746(3):305-13. PubMed ID: 16289370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sterol carrier protein-2 selectively alters lipid composition and cholesterol dynamics of caveolae/lipid raft vs nonraft domains in L-cell fibroblast plasma membranes.
    Atshaves BP; Gallegos AM; McIntosh AL; Kier AB; Schroeder F
    Biochemistry; 2003 Dec; 42(49):14583-98. PubMed ID: 14661971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sorafenib suppresses TGF-β responses by inducing caveolae/lipid raft-mediated internalization/degradation of cell-surface type II TGF-β receptors: Implications in development of effective adjunctive therapy for hepatocellular carcinoma.
    Chung CL; Wang SW; Sun WC; Shu CW; Kao YC; Shiao MS; Chen CL
    Biochem Pharmacol; 2018 Aug; 154():39-53. PubMed ID: 29678520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.